Literature DB >> 8763337

Glutathione and related enzymes in multidrug resistance.

M L O'Brien1, K D Tew.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8763337     DOI： 10.1016/0959-8049(96)00051-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  38 in total

Review 1.  Overcoming drug resistance in ovarian carcinoma.

Authors:  P M Fracasso
Journal:  Curr Oncol Rep       Date:  2001-01       Impact factor: 5.075

2.  Nrf2, a guardian of healthspan and gatekeeper of species longevity.

Authors:  Kaitlyn N Lewis; James Mele; John D Hayes; Rochelle Buffenstein
Journal:  Integr Comp Biol       Date:  2010-05-06       Impact factor: 3.326

3.  The extended-MDR phenotype.

Authors:  R Davey; M Davey
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.

Authors:  Charalambos Andreadis; Phyllis A Gimotty; Peter Wahl; Rachel Hammond; Jane Houldsworth; Stephen J Schuster; Timothy R Rebbeck
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

5.  Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases.

Authors:  C J Henderson; A G Smith; J Ure; K Brown; E J Bacon; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

6.  Pipecolic acid induces oxidative stress in vitro in cerebral cortex of young rats and the protective role of lipoic acid.

Authors:  Giovana Reche Dalazen; Melaine Terra; Carlos Eduardo Diaz Jacques; Juliana G Coelho; Raylane Freitas; Priscila Nicolao Mazzola; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

7.  Association between GSTM1 copy number, promoter variants and susceptibility to urinary bladder cancer.

Authors:  Xuemei Zhang; Jie Lin; Xifeng Wu; Zhongning Lin; Baitang Ning; Susan Kadlubar; Fred F Kadlubar
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

8.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells.

Authors:  Alex M Chen; Min Zhang; Dongguang Wei; Dirk Stueber; Oleh Taratula; Tamara Minko; Huixin He
Journal:  Small       Date:  2009-12       Impact factor: 13.281

9.  Structure-Based Design of Anticancer Prodrug PABA/NO.

Authors:  Xinhua Ji; Ajai Pal; Ravi Kalathur; Xun Hu; Yijun Gu; Joseph E Saavedra; Gregory S Buzard; Aloka Srinivasan; Larry K Keefer; Shivendra V Singh
Journal:  Drug Des Devel Ther       Date:  2008       Impact factor: 4.162

10.  Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences.

Authors:  Delisha A Stewart; Jason H Winnike; Susan L McRitchie; Robert F Clark; Wimal W Pathmasiri; Susan J Sumner
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.